Start-ups @ AMR Conference | Pitching session

Early stage ventures fighting drug resistant bacterial infections in the therapeutics or diagnostics area were invited to apply to pitch at the AMR Conference 2022.

The start-up pitch session was supported by INCATE and partners from the AMR community. They have received the opportunity to make a 5-minute-pitch of their venture in front of potential funders and investors during the start-up pitch session on April 7.

LimmaTech Biologics, represented by Laura Yates, was selected the best pitch and won a 10k EUR prize from award sponsor Vossius, one of the leading IP law firms in Europe and Switzerland.